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These two case reports examine the histories of a father and daughter with respiratory
bronchiolitis-interstitial lung disease. This unusual condition occurs almost exclusively in
smokers and has never previously been reported in ﬁrst-degree relatives.
& 2008 Elsevier Ltd. All rights reserved.Introduction
Respiratory bronchiolitis-interstitial lung disease (RB-ILD) is
an interstitial pneumonia that occurs almost entirely in
smokers. Respiratory bronchiolitis is a common pathological
ﬁnding in smokers’ lungs.1 An exaggerated response to
smoke causes interstitial changes such as peribronchial
inﬂammatory inﬁltrates and alveolar septal thickening.2
Although other idiopathic interstitial pneumonias (IIPs) have
been demonstrated to have a genetic predisposition, the
same is not true for RB-ILD. One recent large study
evaluating familial pulmonary ﬁbrosis (2 or more ﬁrst-Elsevier Ltd. All rights reserved.
ac.uk (J. Maclay),degree relatives with IIP) examined 111 families and found
one family suffering from 3 different subtypes, one of whom
had RB-ILD and the others had idiopathic pulmonary ﬁbrosis
(IPF) and non-speciﬁc interstitial pneumonia (NSIP).3 The
following case reports discuss two ﬁrst-degree family
members both with radiological and pathological evidence
of RB-ILD and further raise the possibility of direct genetic
susceptibility to developing this condition. Consent was
obtained from both patients.
Case 1—The daughter
This 23-year-old female presented with cough, streaky
haemoptysis and exertional breathlessness on a background
of childhood asthma. She was a retired jockey who kept
cats, dogs and birds at home and had a 7 pack-year smoking
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age 17. Clinical examination was normal. Her initial lung
function was normal, but over a number of months she
developed a mild restrictive defect (FEV1/FVC ¼ 2.47/2.92L;
79% and 81% predicted, respectively) and a markedly
reduced DLCO (41% predicted). An exercise test revealed a
peak VO2/kg of 15.6 (40% predicted). HRCT demonstrated
patchy ground glass inﬁltrates in all zones, but with an
upper-zone predominance. This was associated with minor
thickening of interlobular septae in the lower zones and
additional poorly deﬁned centrilobular nodules in the upper
zones (Figure 1). Expiratory scans showed no signiﬁcantFigure 1 Case 1. Transverse inspiratory thin section CT
through the lower zones shows interlobular septal thickening
in conjunction with patchy ground glass inﬁltrates.
Figure 2 Case 1. Thoracoscopic lung biopsy section showing intra
peribronchiolar inﬂammatory changes consistent with the diagnosisdecreased attenuation to suggest functional small airways
disease. Bronchoalveolar lavage and transbronchial biopsy
were non-diagnostic, but thoracoscopic lung biopsy showed
numerous macrophages containing dusky brown cytoplasmic
material ﬁlling bronchioles and alveolar spaces (Figure 2).
This appearance was patchy, not diffuse and in combination
with the radiological ﬁndings was consistent with the
diagnosis of RB-ILD. There was no evidence of asthma or
hypersensitivity pneumonitis. No evidence of sequence
variation in the surfactant protein C (SP-C) genes was
identiﬁed (The John Hopkins University School of Medicine,
DNA Diagnostic Lab). She has clinically deteriorated whilst
on prednisone and azathioprine therapy and continues to
smoke.Case 2—The father
This printer presented aged 41 with slowly progressive
exertional dyspnoea. He had a 30 pack-year smoking history,
kept canaries in an aviary and mucked out for his horses in a
closed stable. Clinical examination was normal. He had
negative avian precipitins and micropolyspora faeni titres
and a normal serum IgE. His initial lung function tests
showed a mild restrictive defect (FEV1/FVC 2.42/3.31L; 66%
and 69% predicted, respectively) with a markedly reduced
DLCO (51% predicted). HRCT demonstrated widespread
ground glass inﬁltrates with a mid to lower zone predomi-
nance associated with centrilobular emphysema with a mid
to upper zone distribution (Figure 3). The ground glass
inﬁltrates were not associated with features of ﬁbrosis.
There was mild bronchial wall thickening. Expiratory scans
did not demonstrate focal areas of decreased attenuation to
suggest functional small airways disease. A transbronchial
biopsy showed chronic inﬂammation in the peribronchial
tissue and BAL revealed 8% eosinophils, 14% neutrophils, 0%
lymphocytes and numerous pigment containing alveolar-alveolar macrophage accumulation, interstitial thickening and
of RB-ILD (haematoxylin and eosin stains) at  40 magniﬁcation.
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Figure 3 Case 2. Transverse inspiratory thin section CT
through lower zones shows diffuse but patchy ground glass
inﬁltrate associated with mild bronchial wall thickening.
Figure 4 Case 2. Surgical lung biopsy section showing evidence
of RBILD with intra-alveolar accumulation of macrophages,
interstitial thickening and peribronchiolar inﬂammation (hae-
matoxylin and eosin stains) at  40 magniﬁcation.
J. Maclay et al.118macrophages. Surgical lung biopsy showed evidence of RB-
ILD with intra-alveolar accumulation of macrophages,
interstitial thickening and peribronchiolar inﬂammation
(Figure 4). No evidence of sequence variation in the SP-C
genes was identiﬁed. He continues to smoke and has been
unresponsive to steroid therapy both symptomatically and
on lung function testing.Other family members
We have studied the remaining siblings (one male smoker,
one female smoker and one female non-smoker) and thesister (non smoker) of the father. None has HRCTevidence of
RB-ILD and all have normal lung function.
Discussion
Although RB-ILD has been inextricably associated with
cigarette smoking, the rarity of clinically signiﬁcant disease
and its presence in two ﬁrst-degree family members must be
considered to be of signiﬁcance. Following extensive review
of the literature, this subtype of IIP has never been reported
to have a speciﬁc hereditary link. The same is not true of
other IIPs. Although the majority of pulmonary ﬁbrosis is
sporadic, familial clustering is widely acknowledged, even in
monozygotic twins and family members brought up in
different environments, suggesting a genetic predisposi-
tion.4 Hodgson et al.5 reported a familial prevalence in 3–4%
of all IPF cases in Finland, thought to be due to common
ancestory. It is presumed that the majority of cases of
familial interstitial pneumonia are of autosomal dominant
inheritance with reduced penetrance although few speciﬁc
genetic loci have been isolated as yet.6 Nogee et al. ﬁrst
identiﬁed mutations on the SP-C gene encoding SP-C in a
mother with DIP and her child with NSIP, and Thomas et al.
describe further SP-C mutations in a large American familial
ﬁbrosis kindred. 7,8 Our patients did not have such mutations
identiﬁed, but we were unable to measure SP-C levels in the
BAL ﬂuid to determine if there was a transcriptional or post-
transcriptional error leading to abnormal proSP-C. No
speciﬁc genetic loci have been implicated in the pathogen-
esis of RB-ILD.
Information regarding the epidemiology of RB-ILD is
sparse. The majority of patients are male, present between
40 and 50 and have a signiﬁcant smoking history. The above
cases provide further evidence that the pathogenesis of this
subtype of ILD may have a genetic component, particularly
as our index case (the daughter) had only smoked for 7
years. Cigarette smoking may modify the risk of developing
pulmonary ﬁbrosis in genetically predisposed individuals,
and patients who develop RB-ILD with only a light smoking
history should be investigated for possible genetic suscept-
ibility along with the rest of their family.
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